Optimizing Procurement and Investments for Medical Items Using DIBOpt (IDA Research Summary)

Abstract

This summary describes enhancements made to IDAs Defense Industrial Base Optimization Model (DIBOpt) to help with budget and procurement planning for chemical, biological, radiological, and nuclear (CBRN) medical countermeasures. The COVID-19 pandemic disrupted global supply chains, which, in turn, exacerbated previously existing challenges with procurement and inventory management of medical items for civilian and military uses. IDA successfully generated a set of products that were used to inform Program Objective Memorandum budget requests for acquiring CBRN medical countermeasures, purchasing plans to meet inventory requirements, and minimizing expirations where possible.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2021
Accession Number
AD1203755

Entities

People

  • Daniel E. Lago
  • Julie C. Kelly
  • Sean M. Oxford

Organizations

  • Institute for Defense Analyses

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Chemical Biological Radiological And Nuclear Defense
  • Countermeasures
  • Covid-19
  • Department Of Defense
  • Department Of Homeland Security
  • Governments
  • Homeland Security
  • Inventory
  • Investments
  • Lead Time
  • Medical Countermeasures
  • Nerve Agents
  • Precision-Guided Munitions
  • Procurement
  • Production
  • Production Rate
  • Shelf Life
  • Supply Chain
  • Unified Combatant Commands

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Defense Acquisition Program Management
  • Systems Analysis and Design